The presentations are available on Connect’s website under the presentations and publications section.

Cybin Inc. (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative ...

These presentations will be accessible on the Events section of the Altimmune website.

Research indicates that early exposure to dogs may mitigate genetic risks associated with eczema in children. A specific gene variation linked to eczema could be neutralized by growing up with a dog, ...

Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately ...

The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved indication for the drug. This also marks the first time an oral JAK ...

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 70+ ...

All of us produce a growth factor—called IL-15—which effectively protects us from cancers. Its role is to boost the ...

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- ...